Traditional focus: 1 disease → 1 custom device.
BioTrillion’s focus: 1 existing device → multiple diseases.
This software-only approach allows one device (our smartphone) to screen for many conditions, by innovating at the intersection of three key domains:
Smartphones are already in 5 billion hands, yet their cameras remain an untapped opportunity for health monitoring. Manufacturers have invested billions to make these devices ubiquitous and sensor-rich; billions more enhance camera hardware each year. Despite this, the primary application is still photography – we are redefining it for healthcare.
The human face harbors more multimodal health information than any other visible anatomic region. It concentrates dense microvasculature, cranial nerves, and ocular structures whose dynamics reflect autonomic, neurologic, cardiovascular, and inflammatory status.
Our HealthySelfie™ iOS app, powered by BioEngine4D, has been independently evaluated to quantify ten (10) medically-established vital signs and biomarkers with ~91% accuracy — with only a smartphone.
We strategically developed our BioEngine4D platform with a specific portfolio of 10 digital biomarkers to provide orthogonal windows into the human body — spanning head to toe. Analyzing these biomarkers, combinatorially, with our DigitalDoctor™ model further unlocks:
Our software-only solution is delivered as a plug-and-play API/SDK that can seamlessly integrate into an enterprise’s existing mobile app on the customer’s smartphone. This allows partners to embed BioTrillion’s analytics into current workflows and data streams with minimal engineering effort.
Traditional clinical trials are often burdened by high costs, logistical hurdles, and protracted timelines, delaying the delivery of life-saving treatments to patients.
The BioEngine4D digital biomarker platform enables remote, precise, and continuous monitoring of medical-grade physiologic endpoints. It minimises subjective assessments, accelerates data capture, and strengthens data integrity — lowering costs and compressing timelines. This shift toward decentralised trials boosts participant compliance and scales efficiently across geographies.
Life insurers face challenges in accurately assessing individual risk, often relying on indirect, generalized, and self-reported data—leading to inaccuracies, fraud, and higher costs.
BioEngine4D offers a precise, data-driven approach: a 10-second smartphone video yields objective longevity insights, shrinking fraud and enabling tailored policies that boost profitability and adoption.
Health insurers struggle with accurately predicting chronic disease risk, often resulting in increased claims and higher premiums due to inefficient risk stratification.
The BioEngine4D platform empowers health insurers with a more accurate and objective method to assess disease risk. By analyzing vital signs from a quick video, our technology helps insurers identify high-risk individuals early, enabling proactive intervention strategies. This reduces healthcare costs, improves patient outcomes, and ultimately yields a more actuarially sustainable insurance model.
Current telehealth lacks real-time vitals, limiting clinical confidence. Our AI turns any smartphone into a multi-vital scanner in seconds — enriching consultations, expanding billable services, and improving outcomes.
Most wellness solutions today require new hardware to buy and ship; then charge and wear everyday. With only a smartphone, our HealthySelfie app lets users measure and track 10 biometrics, early detect disease risks, and act before symptoms strike—unlocking a true “digital doctor” in every pocket.
Historically, the ability to detect signs of disease required in vivo methods, with invasive procedures into the body.
Today, advancements allow much of this information to be gathered ex vivo, non-invasively, through surface-level contact on the body.
In the future, this evolution will continue to advance, enabling the collection of vital health data telemetrically, away from the body.
This progression—from in vivo (invasive), to ex vivo (invasiveless), to telemetrica (contactless)—reflects the ongoing shift away from physical constraints, exponentially enhancing the convenience and scalability of accessing critical health insights.
Our AI models emulate the centuries-old clinical workflow — observe key biomarkers, analyse them combinatorially, and infer disease risk. DigitalDoctor™ extends that capability to anyone with a smartphone, making objective health monitoring vastly more accessible, frequent, and scalable.
| Domain | Role | Clinical | Digital | Advantage |
|---|---|---|---|---|
| Anatomy | Contains Disease Signs | Blood (Sample) | Face (HealthySelfie) | Convenient; Accessible |
| Sensor | Capture Signs | Lab Sensors | Phone Sensors | Frequent; Instant; Scalable to 5B |
| Processor | Combine Signs + Infer Disease | Human Doctor Brain | DigitalDoctor™ AI | Unlimited Combinatorics; Consistency; Accuracy |
BioEngine4D is a technology platform with the potential to transform health monitoring at digital speed and scale for billions of people, establishing a new paradigm in earlier disease detection and better risk prediction.
We are building a future where virtually anyone, anytime, anywhere has instant and accessible health monitoring abilities — providing better care for your health — with only the device you already hold in your hand.
